TY - JOUR
T1 - The dynamic nature of the K-Ras/calmodulin complex can be altered by oncogenic mutations
AU - Abdelkarim, Hazem
AU - Leschinsky, Nicholas
AU - Jang, Hyunbum
AU - Banerjee, Avik
AU - Nussinov, Ruth
AU - Gaponenko, Vadim
N1 - Publisher Copyright:
© 2021 The Author(s)
PY - 2021/12
Y1 - 2021/12
N2 - Oncogenic mutant K-Ras promotes cancer cell proliferation, migration, invasion, and survival by assembling signaling complexes. To date, the functional and structural roles of K-Ras mutations within these complexes are incompletely understood despite their mechanistic and therapeutic significance. Here, we review recent advances in understanding specific binding between K-Ras and the calcium sensor calmodulin. This interaction positively and negatively regulates diverse functions of K-Ras in cancer, suggesting flexibility in K-Ras/calmodulin complex formation. Also, structural data suggest that oncogenic K-Ras likely samples several conformational states, influencing its distinct assemblies with calmodulin and with other proteins. Understanding how K-Ras interacts with calmodulin and with other partners is essential to discovering novel inhibitors of K-Ras in cancer.
AB - Oncogenic mutant K-Ras promotes cancer cell proliferation, migration, invasion, and survival by assembling signaling complexes. To date, the functional and structural roles of K-Ras mutations within these complexes are incompletely understood despite their mechanistic and therapeutic significance. Here, we review recent advances in understanding specific binding between K-Ras and the calcium sensor calmodulin. This interaction positively and negatively regulates diverse functions of K-Ras in cancer, suggesting flexibility in K-Ras/calmodulin complex formation. Also, structural data suggest that oncogenic K-Ras likely samples several conformational states, influencing its distinct assemblies with calmodulin and with other proteins. Understanding how K-Ras interacts with calmodulin and with other partners is essential to discovering novel inhibitors of K-Ras in cancer.
UR - http://www.scopus.com/inward/record.url?scp=85111016372&partnerID=8YFLogxK
U2 - 10.1016/j.sbi.2021.06.008
DO - 10.1016/j.sbi.2021.06.008
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 34311289
AN - SCOPUS:85111016372
SN - 0959-440X
VL - 71
SP - 164
EP - 170
JO - Current Opinion in Structural Biology
JF - Current Opinion in Structural Biology
ER -